StockData
INNVNasdaqServices-Health ServicesFiscal year ends June 30

InnovAge Holding Corp.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 9, 2026
$8.88+0.03 (+0.34%)

Close on Oct 19, 2026

Market cap
$1.21B
P/E (TTM)
–
Dividend yield
–

InnovAge Holding Corp. revenue by segment

By business segment

RevenueFY2026FY2025FY2024FY2023FY2022FY2021FY2020% of revenueYoY
PACE$989.45M$852.71M$762.88M$687.18M$697.40M$635.62M$565.18M100.0%+16.0%
All other$257.00K$990.00K$975.00K$904.00K$1.24M$2.18M$2.02M0.0%-74.0%

By product or service

RevenueFY2026FY2025FY2024FY2023FY2022FY2021FY2020% of revenueYoY
Capitation revenue$988.38M$852.35M$762.57M$686.84M$697.00M$635.32M$564.83M99.9%+16.0%
Other service revenue$1.32M$1.35M$1.29M$1.25M$1.64M$2.48M$2.36M0.1%-1.7%

By region

From the segment and revenue-disaggregation notes of InnovAge's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.